Tech Company Financing Transactions
OrphoMed Funding Round
OrphoMed closed a $2.8 million investment round on 1/18/2016. Investors included private investors.
Transaction Overview
Company Name
Announced On
1/18/2016
Transaction Type
Debt
Amount
$2,816,012
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. 10 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
50 Francisco St. 245
San Francisco, CA 94133
USA
San Francisco, CA 94133
USA
Phone
Website
Email Address
Overview
OrphoMed is a San Francisco Bay Area pharmaceutical company focused on the development of novel first-in-class therapeutic dimer conjugates based on its proprietary DIMERx platform technology.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Gary Phillips
Chief Scientific Officer
Nikhilesh Singh
Vice President
Virginia Sanders
Vice President
Lisa Turner
VP - Finance
Gregory Beyer
VP - Regulatory Affairs
Michelle Usher
Browse more venture capital transactions:
Prev: 1/18/2016: Galvanize venture capital transaction
Next: 1/19/2016: Patreon venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on tech company VC transactions. VC investment data records reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs